Institute for Research in Pharmaceuticals and Medications , Federal University of Paraíba , João Pessoa 58051-900 , Brazil.
Research Laboratory in Materia Medica, School of Pharmacy , Federal University of Bahia , Salvador 40170-290 , Brazil.
J Nat Prod. 2019 Oct 25;82(10):2721-2730. doi: 10.1021/acs.jnatprod.9b00251. Epub 2019 Oct 10.
This study represents the first phytochemical analysis of () and describes new terpenoids obtained from the root bark of this species. The fractionation of the hexane extract from the root bark led to the isolation of two new 28-nor-taraxarenes derivatives, loranthones A and B ( and ), four new tigliane diterpenes (-), three known tigliane diterpenes (-), and three known flexibilene diterpenes, tonantzitlolones A-C (-). The investigation of these compounds and the use of a molecular networking-based prioritization approach afforded two other new 28-nor-taraxarenes, loranthones C and D ( and ). The cytotoxicity of compounds , , and - was evaluated against Vero cells, and their 20% cytotoxic concentration (CC) values varied from 8.7 to 328 μM; antiviral activity was tested against an epidemic Zika virus (ZIKV) strain circulating in Brazil. Six out of 12 compounds (, , -, and ) exhibited significant antiviral effects against ZIKV. Specifically, compounds and offered the most promise as lead compounds as they had a 1.7 and 1.8 log TCID/mL reduction in ZIKV replication, respectively. Together, the present findings have identified terpenoids as potent anti-ZIKV inhibitors and pave the way to the development of possible new treatments against this devastating pathogen.
本研究代表了对 () 的首次植物化学分析,并描述了从该物种的根皮中获得的新三萜类化合物。从根皮的己烷提取物中进行的分级分离得到了两种新的 28-降北美黄连烷衍生物,loranthones A 和 B ( 和 ),四种新的丁香烷二萜 (-),三种已知的丁香烷二萜 (-)和三种已知的 flexibilene 二萜,tonantzitlolones A-C (-)。对这些化合物的研究以及使用基于分子网络的优先级方法提供了另外两种新的 28-降北美黄连烷,loranthones C 和 D ( 和 )。对化合物,, 和 -的细胞毒性进行了评估,对 Vero 细胞的 20%细胞毒性浓度 (CC) 值范围为 8.7 至 328 μM;抗病毒活性针对在巴西流行的寨卡病毒 (ZIKV) 株进行了测试。在 12 种化合物中,有 6 种 (,, -, 和 ) 对 ZIKV 表现出显著的抗病毒作用。具体而言,化合物 和 作为潜在的先导化合物最有希望,因为它们分别使 ZIKV 复制减少了 1.7 和 1.8 log TCID/mL。总之,本研究结果表明萜类化合物是有效的抗 ZIKV 抑制剂,并为开发针对这种破坏性病原体的可能新疗法铺平了道路。